Seven & i Holdings (TYO:3382) revealed on Monday that Canadian retailer Alimentation Couche-Tard (TSE:ATD) is evaluating a proposal to sell a group of stores to address antitrust concerns over their potential $47 billion merger.
In an open letter to shareholders, Seven & i stated it remains engaged in discussions with Couche-Tard, particularly after a key shareholder urged the company to seriously consider the offer. The two firms are now working with financial advisors to assess store divestitures that could help ease regulatory hurdles, though no definitive agreement has been signed yet.
The divestiture discussions come amid heightened antitrust scrutiny, which poses a major challenge to the merger. Seven & i and Couche-Tard are actively seeking buyers for stores that may need to be sold if a deal moves forward.
This renewed engagement follows the collapse of a $55 billion buyout bid led by the Ito founding family in February due to financing difficulties. Initially, Seven & i had dismissed Couche-Tard’s proposal but later reopened talks under shareholder pressure to unlock greater corporate value.
Hedge fund Artisan Partners (NYSE:APAM), a key investor, has also pushed for deeper negotiations with Couche-Tard. In a letter on Sunday, the firm urged Seven & i to prioritize maximizing shareholder returns by seriously evaluating the merger offer.
As discussions continue, market watchers anticipate further developments, particularly regarding regulatory approvals and the potential sale of assets to facilitate the deal.


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 



